Find cancer medicine after dinner together

Dinner between Australian and German scientists Professor Phil Robinson and Volker Haucke led to a breakthrough in the world medical industry in the treatment and cure of cancer as well as dangerous diseases. other human networks.

The idea of ​​using antiviral drugs to prevent lethal diseases such as cancer, HIV and Ebola is currently being tested by a group of scientists from the two countries, formed in one meal. Dinner between two professors in San Francisco, USA 3 years ago.

This can be considered a true revolution in medicine and hopefully save millions of patients worldwide.

Recalling the story three years ago, Professor Robinson recalls: " Then we discussed how to search for a molecule that can block viral substances from entering human body cells. They both realized that there were many similarities . "

The professor added that soon after the two agreed to cooperate with the research and if once successful, the study will be a breakthrough in dealing with most of the dangerous diseases transmitted by the virus.

Earlier, Professor Haucke, of the University of Freie in Berlin, identified two super-molecules out of the 20,000 others he believed would be able to prevent viruses from entering daughter cells. people.

During the partnership, Robinson directly contacted Professor Adam McCluskey of Newcastle University, Sydney, a leading expert in drug development, to develop the two molecules into a drug form.

The effect of antiviral drugs is to prevent the growth and proliferation of harmful viruses in the human body. However, the hope of scientists is that the new drug could immediately prevent from the first point of development of viruses when entering cells and if those viruses are unable to replicate. They will destroy themselves .

The next step of the study is to test the applicability and safety of use on experimental animals before testing for patients. Professor Haucke assesses the likelihood of success, but the process of successful application in new people is the end result.

He also hopes that the study will attract the attention of scientists around the world, contributing to the research and application process for this new drug.